Research project

Mass spectrometry-based analytical methods for quantification and identification of biological responses

The objective of the project is to analyze biological samples, such as skin biopsies and urine, with mass spectrometry to support current and future pre-clinical and clinical research.

The project seeks to identify and quantify drugs and biomarkers from biological samples by analysis with liquid chromatography-mass spectrometry (LC-MS) and other analytical methods. These analyses can either be performed to support other research projects or with a focus on developing of new analytical methods.

A primary goal of the project is to develop a robust method for quantification of dinucleotides that are excreted in urine following DNA damage. Other focus areas include analysis of vitamin D and vismodegib from different biological matrices.  

Researcher

MSc. pharm. and PhD Jonatan Riber Granborg

Project supervisor

Associate Professor, PhD, MSc. Pharm. Catharina Margrethe Lerche

Project period

2022 -

Project collaborators

MSc. pharm. Anne Schmedes, Lillebælt Hospital, Vejle

Sigurd Hermansson, Waters Corporation, Solna, Sverige

Financing

The Lundbeck Foundation

Selected publications

Lerche CM, Philipsen PA, Hermansson S, Heydenreich J, Wulf HC. Quantification of Urinary Thymidine Dimers in Volunteers After Ultraviolet Radiation Using a New UPLC-MS/MS-based Method. Anitcancer Research. 2022 Oct;42(10):5069-5076.